Parenteral drug delivery devices are used for administration of drugs by routes other than the oral mode of dosage. Technological advancement in the area of parenteral drug delivery systems has led to development of innovative devices that enable sophisticated mode of drug targeting and controlled release of parenteral medicines. Parenteral formulations especially intravenous, allows direct access of the drug into the bloodstream and rapid onset of drug action at specific target sites. Parenteral drug delivery systems offers benefits over other dosage forms for drug delivery in critical medical conditions such as nausea, unconsciousness, and during clinical emergency conditions. Parenteral drug delivery systems are efficient in delivery of active drug molecule with poor bioavailability and drugs with narrow therapeutics index.  

Parenteral route of drug delivery offers advantages of speedy onset of drug action. Maintenance of effective drug concentration range of systemic drugs is mandatory for effective treatment. This is achieved by repeated injections, which causes discomfort among patients. Thus, key players are investing in development of novel drug delivery systems which could reduce the patient discomfort level. Parenteral drug delivery devices optimizes the therapeutics index of drugs by providing immediate drug action in systemic level in the desired quantity for treatment. Growing prevalence of cardiac diseases, diabetes, and cancer are the major factors augmenting the growth of the advanced parenteral drug delivery devices market. Rising investment from key players for development of novel mode of administration of new drugs is likely to drive the market growth of advanced parenteral drug delivery devices.

The global advanced parenteral drug delivery devices market can be segmented based on product type, application, end-user, and region. In terms of product type, the global advanced parenteral drug delivery devices market has been segmented into prefillable syringes, injectors cartridges, hypodermic syringes, IV catheters, and others. In terms of applications, the market has been segregated into central nervous system agents, respiratory agents, hormones & related agents, gastrointestinal agents, cardiovascular agents, anti-infective agents, nutritional agents, and genito-urinary agents. In terms of end-user, the market can be segmented into hospitals, clinics, and diagnostic centers, ambulatory surgical centers and others.

Based on region, the global advanced parenteral drug delivery devices market can be segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for a leading share of the global advanced parenteral drug delivery devices market, followed by Europe. Technological advancement in drug delivery devices, the rising patient awareness levels, and growing incidence of chronic diseases are the major factors propelling the growth of the advanced parenteral drug delivery devices market in North America. Asia Pacific is tipped to have huge potential for growth of advanced parenteral drug delivery devices owing to growing prevalence of cardiovascular and other chronic diseases, penetration of key players in this emerging region, large patient population, and rising healthcare expenditure. Latin America, and Middle East & Africa are anticipated to offer considerable growth opportunities for advanced parenteral drug delivery devices during the forecast period, due to penetration of key players, rising disposable incomes, and presence of a large population base.

Key players operating in the global advanced parenteral drug delivery devices market are AptarGroup Incorporated, Amgen Incorporated, Abbott Laboratories, Baxter International Incorporated, Becton, Dickinson and Company, Bristol-Myers Squibb Company, Boston Scientific Corporation, GlaxoSmithKline plc, Roche Holding Limited, Novartis AG, Pfizer, and others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Advanced Parenteral Drug Delivery Devices Market

Pre Book